Savara Inc Share-based Payment Arrangement, Expense
Savara Inc (SVRA) reported Share-based Payment Arrangement, Expense of $7.76 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-11
- Savara Inc share-based payment arrangement, expense for the quarter ending 2026-06-30 was $7.76M, a 190.93% increase year-over-year.
- Savara Inc share-based payment arrangement, expense for the quarter ending 2026-03-31 was $10.73M, a 260.94% increase year-over-year.
- Savara Inc share-based payment arrangement, expense for the quarter ending 2025-12-31 was $5.36M, a 76.38% increase year-over-year.
- Savara Inc share-based payment arrangement, expense for the quarter ending 2025-09-30 was $3.42M, a 44.45% increase year-over-year.
- Savara Inc share-based payment arrangement, expense for fiscal 2025 was $14.42M, a 46.26% increase from fiscal 2024.
- Savara Inc share-based payment arrangement, expense for fiscal 2024 was $9.86M, a 136.00% increase from fiscal 2023.
- Savara Inc share-based payment arrangement, expense for fiscal 2023 was $4.18M, a 104.70% increase from fiscal 2022.
- Savara Inc share-based payment arrangement, expense for fiscal 2022 was $2.04M, a 37.39% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.76M 10-Q · filed 2026-08-11 | $18.49M 10-Q · filed 2026-08-11 | $23.85M derived: sum of 3 quarters · filed 2026-08-11 | $27.27M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $10.73M 10-Q · filed 2026-05-12 | $16.08M derived: sum of 2 quarters · filed 2026-05-12 | $19.51M derived: sum of 3 quarters · filed 2026-05-12 | $22.18M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $5.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $8.78M derived: sum of 2 quarters · filed 2026-03-13 | $11.45M derived: sum of 3 quarters · filed 2026-08-11 | $14.42M 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | $3.42M 10-Q · filed 2025-11-12 | $6.09M derived: sum of 2 quarters · filed 2026-08-11 | $9.07M 10-Q · filed 2025-11-12 | $12.10M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $2.67M 10-Q · filed 2026-08-11 | $5.64M 10-Q · filed 2026-08-11 | $8.68M derived: sum of 3 quarters · filed 2026-08-11 | $11.05M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $2.97M 10-Q · filed 2026-05-12 | $6.01M derived: sum of 2 quarters · filed 2026-05-12 | $8.38M derived: sum of 3 quarters · filed 2026-05-12 | $10.57M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $3.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $5.41M derived: sum of 2 quarters · filed 2026-03-13 | $7.60M derived: sum of 3 quarters · filed 2026-03-13 | $9.86M 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | $2.37M 10-Q · filed 2025-11-12 | $4.57M derived: sum of 2 quarters · filed 2025-11-12 | $6.82M 10-Q · filed 2025-11-12 | $8.19M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $2.20M 10-Q · filed 2025-08-13 | $4.45M 10-Q · filed 2025-08-13 | $5.81M derived: sum of 3 quarters · filed 2025-08-13 | $6.81M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $2.26M 10-Q · filed 2025-05-13 | $3.62M derived: sum of 2 quarters · filed 2025-05-13 | $4.61M derived: sum of 3 quarters · filed 2025-05-13 | $5.57M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $2.36M derived: sum of 2 quarters · filed 2025-03-27 | $3.31M derived: sum of 3 quarters · filed 2025-03-27 | $4.18M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $995.00K 10-Q · filed 2024-11-12 | $1.95M derived: sum of 2 quarters · filed 2024-11-12 | $2.82M 10-Q · filed 2024-11-12 | $3.38M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $958.00K 10-Q · filed 2024-08-12 | $1.82M 10-Q · filed 2024-08-12 | $2.38M derived: sum of 3 quarters · filed 2024-08-12 | $2.83M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $864.00K 10-Q · filed 2024-05-09 | $1.43M derived: sum of 2 quarters · filed 2024-05-09 | $1.88M derived: sum of 3 quarters · filed 2024-05-09 | $2.33M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $561.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $1.01M derived: sum of 2 quarters · filed 2024-03-07 | $1.47M derived: sum of 3 quarters · filed 2024-03-07 | $2.04M 10-K · filed 2024-03-07 | ||||
| 2022-09-30 | $450.00K 10-Q · filed 2023-11-09 | $906.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.48M 10-Q · filed 2023-11-09 | $2.33M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $456.00K 10-Q · filed 2023-08-10 | $1.03M 10-Q · filed 2023-08-10 | $1.88M derived: sum of 3 quarters · filed 2023-08-10 | $2.57M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $574.00K 10-Q · filed 2023-05-15 | $1.43M derived: sum of 2 quarters · filed 2023-05-15 | $2.12M derived: sum of 3 quarters · filed 2023-05-15 | $2.89M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $853.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.54M derived: sum of 2 quarters · filed 2023-03-30 | $2.31M derived: sum of 3 quarters · filed 2023-03-30 | $3.26M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $690.00K 10-Q · filed 2022-11-10 | $1.46M derived: sum of 2 quarters · filed 2022-11-10 | $2.41M 10-Q · filed 2022-11-10 | $3.21M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $771.00K 10-Q · filed 2022-08-11 | $1.72M 10-Q · filed 2022-08-11 | $2.52M derived: sum of 3 quarters · filed 2022-08-11 | $4.46M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $946.00K 10-Q · filed 2022-05-11 | $1.75M derived: sum of 2 quarters · filed 2022-05-11 | $3.68M derived: sum of 3 quarters · filed 2022-05-11 | $4.86M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | $807.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $2.74M derived: sum of 2 quarters · filed 2022-03-30 | $3.91M derived: sum of 3 quarters · filed 2022-03-30 | $5.11M 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $1.93M 10-Q · filed 2020-11-05 | $3.11M derived: sum of 2 quarters · filed 2021-08-12 | $4.30M 10-Q · filed 2021-11-12 | $6.19M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $1.18M 10-Q · filed 2021-08-12 | $2.37M 10-Q · filed 2021-08-12 | $4.25M derived: sum of 3 quarters · filed 2021-11-12 | $5.40M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-03-31 | $1.93M 10-Q · filed 2021-11-12 | $1.19M 10-Q · filed 2020-05-07 | $3.08M derived: sum of 2 quarters · filed 2021-11-12 | $4.23M derived: sum of 3 quarters · filed 2021-11-12 | $5.37M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2019-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $2.29M derived: sum of 2 quarters · filed 2021-03-10 | $3.44M derived: sum of 3 quarters · filed 2021-03-10 | $4.44M 10-K · filed 2021-03-10 | ||||
| 2019-09-30 | $1.15M 10-Q · filed 2020-11-05 | $2.29M derived: sum of 2 quarters · filed 2020-11-05 | $3.29M 10-Q · filed 2020-11-05 | $4.24M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $1.15M 10-Q · filed 2020-08-06 | $2.15M 10-Q · filed 2020-08-06 | $3.09M derived: sum of 3 quarters · filed 2020-08-06 | $5.08M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $1.00M 10-Q · filed 2020-05-07 | $1.95M derived: sum of 2 quarters · filed 2020-05-07 | $3.93M derived: sum of 3 quarters · filed 2020-05-07 | $4.33M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $945.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $2.93M derived: sum of 2 quarters · filed 2020-03-12 | $3.33M derived: sum of 3 quarters · filed 2020-03-12 | $3.74M 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | $1.99M 10-Q · filed 2019-11-07 | $2.38M derived: sum of 2 quarters · filed 2019-11-07 | $2.79M 10-Q · filed 2019-11-07 | $2.99M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $392.00K 10-Q · filed 2019-08-08 | $804.00K 10-Q · filed 2019-08-08 | $1.01M derived: sum of 3 quarters · filed 2019-08-08 | $1.12M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $412.00K 10-Q · filed 2019-05-09 | $614.00K derived: sum of 2 quarters · filed 2019-05-09 | $728.00K derived: sum of 3 quarters · filed 2019-05-09 | $883.00K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $202.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $316.00K derived: sum of 2 quarters · filed 2019-03-13 | $471.00K derived: sum of 3 quarters · filed 2019-03-13 | $552.00K 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | $114.00K 10-Q · filed 2018-11-07 | $269.00K derived: sum of 2 quarters · filed 2018-11-07 | $350.00K 10-Q · filed 2018-11-07 | $405.00K derived: sum of 4 quarters · filed 2018-11-07 | ||||
| 2017-06-30 | $155.00K 10-Q · filed 2018-08-09 | $236.00K 10-Q · filed 2018-08-09 | $291.00K derived: sum of 3 quarters · filed 2018-08-09 | $333.00K derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $81.00K 10-Q · filed 2018-05-09 | $461.00K 10-Q · filed 2017-05-09 | $136.00K derived: sum of 2 quarters · filed 2018-05-09 | $178.00K derived: sum of 3 quarters · filed 2018-05-09 | $229.00K derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2016-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $97.00K derived: sum of 2 quarters · filed 2018-03-14 | $148.00K derived: sum of 3 quarters · filed 2018-03-14 | $209.00K 10-K · filed 2018-03-14 | $2.64M 10-K · filed 2017-03-06 | |||
| 2016-09-30 | $42.00K 10-Q · filed 2017-11-08 | $645.00K 10-Q · filed 2016-11-08 | $93.00K derived: sum of 2 quarters · filed 2017-11-08 | $154.00K 10-Q · filed 2017-11-08 | $1.95M 10-Q · filed 2016-11-08 | -$1.22M derived: sum of 4 quarters · filed 2018-03-14 | ||
| 2016-06-30 | $51.00K 10-Q · filed 2017-08-09 | $647.00K 10-Q · filed 2016-08-09 | $112.00K 10-Q · filed 2017-08-09 | $1.31M 10-Q · filed 2016-08-09 | -$1.26M derived: sum of 3 quarters · filed 2018-03-14 | -$715.00K derived: sum of 4 quarters · filed 2018-03-14 | ||
| 2016-03-31 | $659.00K 10-Q · filed 2017-05-09 | -$1.31M derived: sum of 2 quarters · filed 2018-03-14 | -$766.00K derived: sum of 3 quarters · filed 2018-03-14 | -$254.00K derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2015-12-31 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$1.43M derived: sum of 2 quarters · filed 2018-03-14 | -$913.00K derived: sum of 3 quarters · filed 2018-03-14 | $153.00K 10-K · filed 2018-03-14 | $2.67M 10-K · filed 2016-03-14 | |||
| 2015-09-30 | $544.00K 10-Q · filed 2016-11-08 | $1.06M derived: sum of 2 quarters · filed 2016-11-08 | $2.12M 10-Q · filed 2016-11-08 | $2.64M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-06-30 | $512.00K 10-Q · filed 2016-08-09 | $1.58M 10-Q · filed 2016-08-09 | $2.10M derived: sum of 3 quarters · filed 2017-03-06 | $2.79M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-03-31 | $1.07M 10-Q · filed 2016-05-06 | $1.58M derived: sum of 2 quarters · filed 2017-03-06 | $2.27M derived: sum of 3 quarters · filed 2017-03-06 | $2.70M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2014-12-31 | $518.93K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $1.21M derived: sum of 2 quarters · filed 2017-03-06 | $1.63M derived: sum of 3 quarters · filed 2017-03-06 | $2.03M 10-K · filed 2017-03-06 | ||||
| 2014-09-30 | $689.23K 10-Q · filed 2014-10-31 | $1.11M derived: sum of 2 quarters · filed 2014-10-31 | $1.51M 10-Q · filed 2014-10-31 | $1.95M derived: sum of 4 quarters · filed 2015-03-24 | ||||
| 2014-06-30 | $424.38K 10-Q · filed 2014-08-11 | $823.84K 10-Q · filed 2014-08-11 | $1.26M derived: sum of 3 quarters · filed 2015-03-24 | $1.71M derived: sum of 4 quarters · filed 2015-03-24 | ||||
| 2014-03-31 | $399.45K 10-Q · filed 2014-05-05 | $840.43K derived: sum of 2 quarters · filed 2015-03-24 | $1.28M derived: sum of 3 quarters · filed 2015-03-24 | $1.65M derived: sum of 4 quarters · filed 2015-03-24 | ||||
| 2013-12-31 | $440.98K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24 | $883.31K derived: sum of 2 quarters · filed 2015-03-24 | $1.25M derived: sum of 3 quarters · filed 2015-03-24 | $1.60M 10-K · filed 2015-03-24 | $1.60M 10-K · filed 2014-03-26 | |||
| 2013-09-30 | $442.33K 10-Q · filed 2014-10-31 | $807.47K derived: sum of 2 quarters · filed 2014-10-31 | $1.16M 10-Q · filed 2014-10-31 | $1.54M derived: sum of 4 quarters · filed 2014-10-31 | ||||
| 2013-06-30 | $365.14K 10-Q · filed 2014-08-11 | $716.69K 10-Q · filed 2014-08-11 | $1.10M derived: sum of 3 quarters · filed 2014-08-11 | $1.46M derived: sum of 4 quarters · filed 2014-08-11 | ||||
| 2013-03-31 | $351.56K 10-Q · filed 2014-05-05 | $737.01K derived: sum of 2 quarters · filed 2014-05-05 | $1.10M derived: sum of 3 quarters · filed 2014-05-05 | |||||
| 2012-12-31 | $385.46K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $745.00K derived: sum of 2 quarters · filed 2014-03-26 | $1.46M 10-K · filed 2014-03-26 | |||||
| 2012-09-30 | $359.54K 10-Q · filed 2013-11-04 | $1.07M 10-Q · filed 2013-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |